Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 30, 2008
Grant Date -
Nov 29, 2007
app pub date -
May 25, 2004
filing date -
May 26, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to use of Ulinastatin and its pharmaceutical composition for treating and/or preventing Severe Acute Respiratory Syndrome (SARS). Ulinastatin is effective for treating and/or preventing SARS, particularly Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS). Ulinastatin is generally used as the pharmaceutical composition, preferably in the form of freeze-dried powder or aqueous solution for injection.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully